Functional expression, characterization, and purification of the catalytic domain of human 11-β-hydroxysteroid dehydrogenase type 1

被引:51
|
作者
Walker, EA
Clark, AM
Hewison, M
Ride, JP
Stewart, PM
机构
[1] Univ Birmingham, Div Med Sci, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England
关键词
D O I
10.1074/jbc.M011142200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
11-beta -hydroxysteroid dehydrogenase type 1 catalyzes the conversion of cortisone to hormonally active cortisol and has been implicated in the pathogenesis of a number of disorders including insulin resistance and obesity. The enzyme is a glycosylated membrane-bound protein that has proved difficult to purify in an active state. Extracted enzyme typically loses the reductase properties seen in intact cells and shows principally dehydrogenase activity. The C-terminal catalytic domain is known to contain a disulfide bond and is located within the lumen of the endoplasmic reticulum, anchored to the membrane by a single N-terminal transmembrane domain. We report here the functional expression of the catalytic domain of the human enzyme, without the transmembrane domain and the extreme N terminus, in Escherichia coli, Moderate levels of soluble active protein were obtained using an N-terminal fusion with thioredoxin and a 6xHis tag. In contrast, the inclusion of a 6xHis tag at the C terminus adversely affected protein solubility and activity. However, the highest levels of active protein were obtained using a construct expressing the untagged catalytic domain. Nonreducing electrophoresis revealed the presence of both monomeric and dimeric disulfide bonded forms; however, mutation of a nonconserved cysteine residue resulted in a recombinant protein with no intermolecular disulfide bonds but full enzymatic activity. Using the optimal combination of plasmid construct and E, coli host strain, the recombinant protein was purified to apparent homogeneity by single step affinity chromatography, The purified protein possessed both dehydrogenase and reductase activities with a K-m of 1.4 muM for cortisol and 9.5 muM for cortisone. This study indicates that glycosylation, the N-terminal region including the transmembrane helix, and intermolecular disulfide bonds are not essential for enzyme activity and that expression in bacteria can provide active recombinant protein for future structural and functional studies.
引用
收藏
页码:21343 / 21350
页数:8
相关论文
共 50 条
  • [31] Expression of 11beta-hydroxysteroid-dehydrogenase type 2 in human thymus
    Almanzar, Giovanni
    Mayerl, Christina
    Seitz, Jan-Christoph
    Hoefner, Kerstin
    Brunner, Andrea
    Wild, Vanessa
    Jahn, Daniel
    Geier, Andreas
    Fassnacht, Martin
    Prelog, Martina
    STEROIDS, 2016, 110 : 35 - 40
  • [32] Nonylphenol-induced hyperadrenalism can be reversed/alleviated by inhibiting of 11-β hydroxysteroid dehydrogenase type 1
    Chang, Ling-Ling
    Wun, Wan-Song A.
    Wang, Paulus S.
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2016, 44 : 1 - 12
  • [33] Purification and characterization of hamster liver microsomal 7α-hydroxycholesterol dehydrogenase -: Similarity to type I 11β-hydroxysteroid dehydrogenase
    Song, W
    Chen, JM
    Dean, WL
    Redinger, RN
    Prough, RA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (26) : 16223 - 16228
  • [34] Purification, characterization and primary structure of 11 beta-hydroxysteroid dehydrogenase type I from human liver.
    Schiebler, L
    Maser, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 45 - 45
  • [35] Increased expression of 11β-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes
    Abdallah, BM
    Beck-Nielsen, H
    Gaster, M
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (10) : 627 - 634
  • [36] 17β-hydroxysteroid dehydrogenase type 11 (Pan1b) expression in human prostate cancer
    Nakamura, Y.
    Suzuki, T.
    Arai, Y.
    Sasano, H.
    NEOPLASMA, 2009, 56 (04) : 317 - 320
  • [37] Guinea pig 11β-hydroxysteroid dehydrogenase type 1:: primary structure and catalytic properties
    Pu, X
    Yang, K
    STEROIDS, 2000, 65 (03) : 148 - 156
  • [38] Expression and NNK reducing activities of carbonyl reductase and 11β-hydroxysteroid dehydrogenase type 1 in human lung
    Finckh, C
    Atalla, A
    Nagel, G
    Stinner, B
    Maser, E
    CHEMICO-BIOLOGICAL INTERACTIONS, 2001, 130 (1-3) : 761 - 773
  • [39] Expression of 11β-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells
    Freeman, L
    Hewison, M
    Hughes, SV
    Evans, KN
    Hardie, D
    Means, TK
    Chakraverty, R
    BLOOD, 2005, 106 (06) : 2042 - 2049
  • [40] 11-β hydroxysteroid dehydrogenase inhibits COX-2 expression in young rats.
    Yao, B
    Harris, RC
    Zhang, MZ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 327A - 327A